MeSH D006474 - hemorrhagic disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006402:Hematologic diseases
D000347:Afibrinogenemia
D001606:Bernard-soulier syndrome
0 Companies
0 Drugs
Success rate
D002836:Hemophilia b
D004211:Disseminated intravascular coagulation
0 Companies
0 Drugs
Success rate
D005166:Factor v deficiency
0 Companies
0 Drugs
Success rate
D005168:Factor vii deficiency
D005173:Factor xi deficiency
0 Companies
0 Drugs
Success rate
D005175:Factor xii deficiency
0 Companies
0 Drugs
Success rate
D005177:Factor xiii deficiency
0 Companies
0 Drugs
Success rate
D006467:Hemophilia a
D010981:Platelet storage pool deficiency
0 Companies
0 Drugs
Success rate
D013920:Essential thrombocythemia
D014813:Vitamin k deficiency
0 Companies
0 Drugs
Success rate
D014842:Von willebrand diseases
D014884:Waterhouse-friderichsen syndrome
0 Companies
0 Drugs
Success rate
D014923:Wiskott-aldrich syndrome
0 Companies
0 Drugs
Success rate
D016553:Thrombocytopenic purpura idiopathic
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
0%0/2
Phase 3
50%1/2
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use